High expression of phosphorylated 4E-binding protein 1 is an adverse prognostic factor in esophageal squamous cell carcinoma

Virchows Archiv

Volumn 458, Issue 2, 2011, Pages 171-178

  Yeh, Chi Ju ^a   Chuang, Wen Yu ^a   Chao, Yin Kai ^a   Liu, Yun Hen ^a   Chang, Yu Sun ^a   Kuo, Shao Yun ^a   Tseng, Chen Kan ^a   Chang, Hsien Kun ^a   Hsueh, Chuen ^a  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

Author keywords

Cancer; Esophagus; Phosphorylated 4E binding protein 1 (p 4E BP1); Squamous cell carcinoma; Survival

Indexed keywords

INITIATION FACTOR 4E BINDING PROTEIN 1; THREONINE;

ADULT; ARTICLE; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FEMALE; HAZARD RATIO; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; CARCINOMA, SQUAMOUS CELL; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; NEOPLASM STAGING; PHOSPHOPROTEINS; PHOSPHORYLATION; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; TUMOR MARKERS, BIOLOGICAL;

EID: 79951717102     PISSN: 09456317     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00428-010-0994-5     Document Type: Article

References (24)

1. G Armengol F Rojo J Castellví C Iglesias M Cuatrecasas B Pons J Baselga S Ramón y Cajal 2007 4E-binding protein 1: a key molecular "funnel factor" in human cancer with clinical implications Cancer Res 67 7551 7555 1:CAS:528:DC%2BD2sXptVGls70%3D 10.1158/0008-5472.CAN-07-0881 17699757 (Pubitemid 47281345)
2. KJ Heesom A Gampel H Mellor RM Denton 2001 Cell cycle-dependent phosphorylation of the translational repressor eIF-4E binding protein-1 (4E-BP1) Curr Biol 11 1374 1379 1:CAS:528:DC%2BD3MXmvVyru7Y%3D 10.1016/S0960-9822(01) 00422-5 11553333 (Pubitemid 32835880)
3. I Topisirovic M Ruiz-Gutierrez KL Borden 2004 Phosphorylation of the eukaryotic translation initiation factor eIF4E contributes to its transformation and mRNA transport activities Cancer Res 64 8639 8642 1:CAS:528: DC%2BD2cXhtVCjs73L 10.1158/0008-5472.CAN-04-2677 15574771 (Pubitemid 39552077)
4. J Averous CG Proud 2006 When translation meets transformation: the mTOR story Oncogene 25 6423 6435 1:CAS:528:DC%2BD28XhtVOlsrrO 10.1038/sj.onc.1209887 17041627 (Pubitemid 44582286)
5. F Rojo L Najera J Lirola J Jiménez M Guzmán MD Sabadell J Baselga S Ramon y Cajal 2007 4E-binding protein 1, a cell signaling hallmark in breast cancer that correlates with pathologic grade and prognosis Clin Cancer Res 13 81 89 1:CAS:528:DC%2BD2sXotlem 10.1158/1078-0432.CCR-06-1560 17200342 (Pubitemid 46121856)
6. J Castellvi A Garcia F Rojo C Ruiz-Marcellan A Gil J Baselga S Ramon y Cajal 2006 Phosphorylated 4E binding protein 1: a hallmark of cell signaling that correlates with survival in ovarian cancer Cancer 107 1801 1811 1:CAS:528:DC%2BD28Xht1Cms7bJ 10.1002/cncr.22195 16983702 (Pubitemid 44582949)
7. S Benavente R Vergés E Hermosilla V Fumanal N Casanova A García S Ramón Y Cajal J Giralt 2009 Overexpression of phosphorylated 4E-BP1 predicts for tumor recurrence and reduced survival in cervical carcinoma treated with postoperative radiotherapy Int J Radiat Oncol Biol Phys 75 1316 1322 1:CAS:528:DC%2BD1MXhsVGmtrnF 10.1016/j.ijrobp.2009.01.004 19362787
8. J Castellvi A Garcia C Ruiz-Marcellan J Hernández-Losa V Peg M Salcedo A Gil-Moreno S Ramon y Cajal 2009 Cell signaling in endometrial carcinoma: phosphorylated 4E-binding protein-1 expression in endometrial cancer correlates with aggressive tumors and prognosis Hum Pathol 40 1418 1426 1:CAS:528:DC%2BD1MXhtFamsbzJ 10.1016/j.humpath.2008.12.019 19428047
9. EF Petricoin 3rd V Espina RP Araujo B Midura C Yeung X Wan GS Eichler DJ Johann Jr S Qualman M Tsokos K Krishnan LJ Helman LA Liotta 2007 Phosphoprotein pathway mapping: akt/mammalian target of rapamycin activation is negatively associated with childhood rhabdomyosarcoma survival Cancer Res 67 3431 3440 1:CAS:528:DC%2BD2sXksVGksbs%3D 10.1158/0008-5472.CAN-06-1344 17409454 (Pubitemid 46724884)
10. KE O'Reilly M Warycha MA Davies V Rodrik XK Zhou H Yee D Polsky AC Pavlick N Rosen N Bhardwaj G Mills I Osman 2009 Phosphorylated 4E-BP1 is associated with poor survival in melanoma Clin Cancer Res 15 2872 2878 10.1158/1078-0432.CCR-08-2336 19336517
11. G Hou L Xue Z Lu T Fan F Tian Y Xue 2007 An activated mTOR/p70S6K signaling pathway in esophageal squamous cell carcinoma cell lines and inhibition of the pathway by rapamycin and siRNA against mTOR Cancer Lett 253 236 248 1:CAS:528:DC%2BD2sXnsFKqsLw%3D 10.1016/j.canlet.2007.01.026 17360108 (Pubitemid 47017539)
12. Z Salehi F Mashayekhi 2006 Expression of the eukaryotic translation initiation factor 4E (eIF4E) and 4E-BP1 in esophageal cancer Clin Biochem 39 404 409 1:CAS:528:DC%2BD28XjvVGisbc%3D 10.1016/j.clinbiochem.2005.11.007 16375881
13. S Avdulov S Li V Michalek D Burrichter M Peterson DM Perlman JC Manivel N Sonenberg D Yee PB Bitterman VA Polunovsky 2004 Activation of translation complex eIF4F is essential for the genesis and maintenance of the malignant phenotype in human mammary epithelial cells Cancer Cell 5 553 563 1:CAS:528:DC%2BD2cXltlGgsL4%3D 10.1016/j.ccr.2004.05.024 15193258 (Pubitemid 38748917)
14. S Huang PJ Houghton 2003 Targeting mTOR signaling for cancer therapy Curr Opin Pharmacol 3 371 373 1:CAS:528:DC%2BD3sXlvFGju78%3D 10.1016/S1471-4892(03) 00071-7 12901945 (Pubitemid 36908940)
15. F Meric-Bernstam AM Gonzalez-Angulo 2009 Targeting the mTOR signaling network for cancer therapy J Clin Oncol 27 2278 2287 1:CAS:528: DC%2BD1MXlvFOgs7k%3D 10.1200/JCO.2008.20.0766 19332717
16. G Hou Q Zhang L Wang M Liu J Wang L Xue 2010 mTOR inhibitor rapamycin alone or combined with cisplatin inhibits growth of esophageal squamous cell carcinoma in nude mice Cancer Lett 289 248 254 10.1016/j.canlet.2009.09.015
17. AC Gingras B Raught SP Gygi A Niedzwiecka M Miron SK Burley RD Polakiewicz A Wyslouch-Cieszynska R Aebersold N Sonenberg 2001 Hierarchical phosphorylation of the translation inhibitor 4E-BP1 Genes Dev 15 2852 2864 1:CAS:528:DC%2BD3MXotlalt78%3D 10.1101/gad.887201 11691836 (Pubitemid 32295062)
18. Ayuso MI, Hernández-Jiménez M, Martin ME, Salinas M, Alcázar A (2010) A new hierarchical phosphorylation pathway of the translational repressor eIF4E-binding protein 1 (4E-BP1) in ischemia-reperfusion stress. J Biol Chem. doi: 10.1074/jbc.M110.135103
19. J Boone FJ Ten Kate GJ Offerhaus PJ van Diest IH Rinkes R van Hillegersberg 2008 mTOR in squamous cell carcinoma of the oesophagus: a potential target for molecular therapy? J Clin Pathol 61 909 913 1:STN:280:DC%2BD1cvotVyqug%3D%3D 10.1136/jcp.2008.055772 18474542
20. A Yoshioka H Miyata Y Doki T Yasuda M Yamasaki M Motoori K Okada J Matsuyama Y Makari I Sohma S Takiguchi Y Fujiwara M Monden 2008 The activation of Akt during preoperative chemotherapy for esophageal cancer correlates with poor prognosis Oncol Rep 19 1099 1107 1:CAS:528:DC%2BD1cXmtFKru7s%3D 18425364
21. Hirashima K, Baba Y, Watanabe M, Karashima RI, Sato N, Imamura Y, Hiyoshi Y, Nagai Y, Hayashi N, Iyama KI, Baba H (2010) Phosphorylated mTOR expression is associated with poor prognosis for patients with esophageal squamous cell carcinoma. Ann Surg Oncol. doi: 10.1245/s10434-010-1040-1
22. QB She E Halilovic Q Ye W Zhen S Shirasawa T Sasazuki DB Solit N Rosen 2010 4E-BP1 is a key effector of the oncogenic activation of the AKT and ERK signaling pathways that integrates their function in tumors Cancer Cell 18 39 51 1:CAS:528:DC%2BC3cXpslSjt7k%3D 10.1016/j.ccr.2010.05.023 20609351
23. E van Meerten A van der Gaast 2005 Systemic treatment for oesophageal cancer Eur J Cancer 41 664 672 10.1016/j.ejca.2004.10.030 15763640 (Pubitemid 40342547)
24. C Mariette G Piessen JP Triboulet 2007 Therapeutic strategies in oesophageal carcinoma: role of surgery and other modalities Lancet Oncol 8 545 553 10.1016/S1470-2045(07)70172-9 17540306 (Pubitemid 46813024)